{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:41:46Z","timestamp":1790170906738,"version":"4.1.0"},"reference-count":223,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2019,11,30]],"date-time":"2019-11-30T00:00:00Z","timestamp":1575072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["293392, 319195"],"award-info":[{"award-number":["293392, 319195"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>MicroRNAs are post-transcriptional regulators of gene expression, crucial for neuronal differentiation, survival, and activity. Age-related dysregulation of microRNA biogenesis increases neuronal vulnerability to cellular stress and may contribute to the development and progression of neurodegenerative diseases. All major neurodegenerative disorders are also associated with oxidative stress, which is widely recognized as a potential target for protective therapies. Albeit often considered separately, microRNA networks and oxidative stress are inextricably entwined in neurodegenerative processes. Oxidative stress affects expression levels of multiple microRNAs and, conversely, microRNAs regulate many genes involved in an oxidative stress response. Both oxidative stress and microRNA regulatory networks also influence other processes linked to neurodegeneration, such as mitochondrial dysfunction, deregulation of proteostasis, and increased neuroinflammation, which ultimately lead to neuronal death. Modulating the levels of a relatively small number of microRNAs may therefore alleviate pathological oxidative damage and have neuroprotective activity. Here, we review the role of individual microRNAs in oxidative stress and related pathways in four neurodegenerative conditions: Alzheimer\u2019s (AD), Parkinson\u2019s (PD), Huntington\u2019s (HD) disease, and amyotrophic lateral sclerosis (ALS). We also discuss the problems associated with the use of oversimplified cellular models and highlight perspectives of studying microRNA regulation and oxidative stress in human stem cell-derived neurons.<\/jats:p>","DOI":"10.3390\/ijms20236055","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T10:50:45Z","timestamp":1575283845000},"page":"6055","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":187,"title":["Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0534-8028","authenticated-orcid":false,"given":"Julia","family":"Konovalova","sequence":"first","affiliation":[{"name":"Institute of Biotechnology, HiLIFE, University of Helsinki, 00014 Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmytro","family":"Gerasymchuk","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology, HiLIFE, University of Helsinki, 00014 Helsinki, Finland"},{"name":"Institute of Molecular Biology and Genetics, NASU, Kyiv 03143, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmari","family":"Parkkinen","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology, HiLIFE, University of Helsinki, 00014 Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Chmielarz","sequence":"additional","affiliation":[{"name":"Department of Brain Biochemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4755-5981","authenticated-orcid":false,"given":"Andrii","family":"Domanskyi","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology, HiLIFE, University of Helsinki, 00014 Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Erkkinen, M.G., Kim, M.O., and Geschwind, M.D. (2018). Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harb Perspect. Biol., 10.","DOI":"10.1101\/cshperspect.a033118"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic Lateral Sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Collaborators","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative Stress, Synaptic Dysfunction, and Alzheimer\u2019s Disease","volume":"57","author":"Tonnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-160205","article-title":"Oxidative stress and Huntington\u2019s disease: The good, the bad, and the ugly","volume":"5","author":"Kumar","year":"2016","journal-title":"J. Huntingtons Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","article-title":"Oxidative stress in neurodegenerative diseases","volume":"53","author":"Niedzielska","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.redox.2018.01.008","article-title":"13 reasons why the brain is susceptible to oxidative stress","volume":"15","author":"Cobley","year":"2018","journal-title":"Redox Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Curr. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2525967","DOI":"10.1155\/2017\/2525967","article-title":"Oxidative stress in neurodegenerative diseases: From molecular mechanisms to clinical applications","volume":"2017","author":"Liu","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The role of oxidative stress in neurodegenerative diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.freeradbiomed.2013.04.010","article-title":"Antioxidants as therapies: Can we improve on nature?","volume":"66","author":"Murphy","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fphar.2019.00033","article-title":"Nrf2\/ARE pathway modulation by dietary energy regulation in neurological disorders","volume":"10","author":"Vasconcelos","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1126\/science.aaa1738","article-title":"Gene expression. MicroRNA control of protein expression noise","volume":"348","author":"Schmiedel","year":"2015","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1242\/dev.144337","article-title":"MicroRNAs in neural development: From master regulators to fine-tuners","volume":"144","author":"Rajman","year":"2017","journal-title":"Development"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tins.2012.01.004","article-title":"MicroRNAs in neuronal function and dysfunction","volume":"35","author":"Im","year":"2012","journal-title":"Trends Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1253","article-title":"Dicer is essential for mouse development","volume":"35","author":"Bernstein","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ygeno.2007.01.004","article-title":"One Argonaute family member, Eif2c2 (Ago2), is essential for development and appears not to be involved in DNA methylation","volume":"89","author":"Morita","year":"2007","journal-title":"Genomics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1002\/dvdy.22109","article-title":"Different timings of Dicer deletion affect neurogenesis and gliogenesis in the developing mouse central nervous system","volume":"238","author":"Otaegi","year":"2009","journal-title":"Dev. Dyn."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1140481","article-title":"A MicroRNA feedback circuit in midbrain dopamine neurons","volume":"317","author":"Kim","year":"2007","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/jmcb\/mjq008","article-title":"Wnt1-cre-mediated conditional loss of Dicer results in malformation of the midbrain and cerebellum and failure of neural crest and dopaminergic differentiation in mice","volume":"2","author":"Huang","year":"2010","journal-title":"J. Mol. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.4815-07.2008","article-title":"Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus","volume":"28","author":"Davis","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1242\/dev.025080","article-title":"miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex","volume":"135","author":"Pulvers","year":"2008","journal-title":"Development"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e2813","DOI":"10.1038\/cddis.2017.214","article-title":"Dicer and microRNAs protect adult dopamine neurons","volume":"8","author":"Chmielarz","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature09830","article-title":"DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration","volume":"471","author":"Kaneko","year":"2011","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mcn.2013.10.009","article-title":"Dicer expression is essential for adult midbrain dopaminergic neuron maintenance and survival","volume":"58","author":"Pang","year":"2014","journal-title":"Mol. Cell Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1093\/hmg\/ddq311","article-title":"Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration","volume":"19","author":"Hebert","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20070823","article-title":"Cerebellar neurodegeneration in the absence of microRNAs","volume":"204","author":"Schaefer","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14835","DOI":"10.1523\/JNEUROSCI.3030-10.2010","article-title":"MicroRNA loss enhances learning and memory in mice","volume":"30","author":"Konopka","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1523\/JNEUROSCI.4251-13.2014","article-title":"Hypothalamic miR-103 protects from hyperphagic obesity in mice","volume":"34","author":"Vinnikov","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1073\/pnas.0801689105","article-title":"Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration","volume":"105","author":"Cuellar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mang, G.M., Pradervand, S., Du, N.H., Arpat, A.B., Preitner, F., Wigger, L., Gatfield, D., and Franken, P. (2015). A neuron-specific deletion of the microRNA-processing enzyme DICER induces severe but transient obesity in mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116760"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1084\/jem.20100451","article-title":"Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction","volume":"207","author":"Schaefer","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrn2763","article-title":"microRNAs at the synapse","volume":"10","author":"Schratt","year":"2009","journal-title":"Nat. Rev. Neurosci"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Antoniou, A., Khudayberdiev, S., Idziak, A., Bicker, S., Jacob, R., and Schratt, G. (2018). The dynamic recruitment of TRBP to neuronal membranes mediates dendritogenesis during development. EMBO Rep., 19.","DOI":"10.15252\/embr.201744853"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fnmol.2018.00455","article-title":"microRNAs Sculpt Neuronal Communication in a Tight Balance That Is Lost in Neurological Disease","volume":"11","author":"Thomas","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/emmm.201201986","article-title":"MicroRNAs in age-related diseases","volume":"5","author":"Dimmeler","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nrn2726","article-title":"Understanding microRNAs in neurodegeneration","volume":"10","author":"Eacker","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fncel.2013.00136","article-title":"The interplay of microRNA and neuronal activity in health and disease","volume":"7","author":"Eacker","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"ref_46","first-page":"40","article-title":"RISC in PD: The impact of microRNAs in Parkinson\u2019s disease cellular and molecular pathogenesis","volume":"6","author":"Hallegger","year":"2013","journal-title":"Front. Mol. Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2011.12.046","article-title":"MicroRNAs in Parkinson\u2019s disease","volume":"46","author":"Mouradian","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2010.03.106","article-title":"MicroRNAs and deregulated gene expression networks in neurodegeneration","volume":"1338","author":"Sonntag","year":"2010","journal-title":"Brain Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1093\/nar\/gkv328","article-title":"The many faces of Dicer: The complexity of the mechanisms regulating Dicer gene expression and enzyme activities","volume":"43","author":"Koralewska","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Leggio, L., Vivarelli, S., L\u2019Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Marchetti, B., and Iraci, N. (2017). microRNAs in Parkinson\u2019s disease: From pathogenesis to novel diagnostic and therapeutic approaches. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122698"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.15252\/embj.201488142","article-title":"miRNAs at the interface of cellular stress and disease","volume":"33","author":"Emde","year":"2014","journal-title":"EMBO J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.15252\/embj.201490493","article-title":"Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: A new mechanism for ALS","volume":"34","author":"Emde","year":"2015","journal-title":"EMBO J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4968321","DOI":"10.1155\/2018\/4968321","article-title":"From oxidative stress damage to pathways, networks, and autophagy via MicroRNAs","volume":"2018","author":"Engedal","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4103\/1673-5374.217328","article-title":"Can we treat neurodegenerative diseases by preventing an age-related decline in microRNA expression?","volume":"12","author":"Vinnikov","year":"2017","journal-title":"Neural Regen. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cell.2011.09.041","article-title":"An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma","volume":"147","author":"Sumazin","year":"2011","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-016-0188-8","article-title":"Recent global trends in the prevalence and incidence of dementia, and survival with dementia","volume":"8","author":"Prince","year":"2016","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainresbull.2016.06.005","article-title":"Oxidative stress, protein modification and Alzheimer disease","volume":"133","author":"Tramutola","year":"2017","journal-title":"Brain Res. Bull."},{"key":"ref_59","first-page":"421","article-title":"The genetic landscape of Alzheimer disease: Clinical implications and perspectives","volume":"18","author":"Sleegers","year":"2015","journal-title":"Genetics Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/YCO.0b013e32816ebc7b","article-title":"The epidemiology of the dementias: An update","volume":"20","author":"Qiu","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mad.2016.12.003","article-title":"Oxidative stress and pro-inflammatory cytokines may act as one of the signals for regulating microRNAs expression in Alzheimer\u2019s disease","volume":"162","author":"Prasad","year":"2017","journal-title":"Mech. Ageing Dev."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Lanoisel\u00e9e, H.-M., Nicolas, G., Wallon, D., Rovelet-Lecrux, A., Lacour, M., Rousseau, S., Richard, A.-C., Pasquier, F., Rollin-Sillaire, A., and Martinaud, O. (2017). APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002270"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-3-10","article-title":"MicroRNAs can regulate human APP levels","volume":"3","author":"Patel","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.nbd.2008.11.009","article-title":"MicroRNA regulation of Alzheimer\u2019s Amyloid precursor protein expression","volume":"33","author":"Bergmans","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2014.04.026","article-title":"MicroRNA-135a and -200b, potential Biomarkers for Alzheimer\u05f3s disease, regulate \u03b2 secretase and amyloid precursor protein","volume":"1583","author":"Liu","year":"2014","journal-title":"Brain Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"24314","DOI":"10.18632\/oncotarget.15149","article-title":"MiR-124-3p attenuates hyperphosphorylation of Tau protein-induced apoptosis via caveolin-1-PI3K\/Akt\/GSK3\u03b2 pathway in N2a\/APP695swe cells","volume":"8","author":"Kang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"31298","DOI":"10.1074\/jbc.M112.366336","article-title":"MicroRNA-153 physiologically inhibits expression of amyloid-\u03b2 precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients","volume":"287","author":"Long","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.febslet.2015.02.001","article-title":"MicroRNA-138 promotes tau phosphorylation by targeting retinoic acid receptor alpha","volume":"589","author":"Wang","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mad.2016.01.002","article-title":"Simultaneous activation of Nrf2 and elevation of antioxidant compounds for reducing oxidative stress and chronic inflammation in human Alzheimer\u2019s disease","volume":"153","author":"Prasad","year":"2016","journal-title":"Mech. Ageing Dev."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Amakiri, N., Kubosumi, A., Tran, J., and Reddy, P.H. (2019). Amyloid beta and microRNAs in Alzheimer\u2019s disease. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00430"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/jsbi.2000.4274","article-title":"Review: Alzheimer\u2019s amyloid \u03b2-peptide-associated free radical oxidative stress and neurotoxicity","volume":"130","author":"Varadarajan","year":"2000","journal-title":"J. Struct. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Li, J.J., Dolios, G., Wang, R., and Liao, F.-F. (2014). Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal icroRNA expression. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090770"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","article-title":"The expression of microRNA miR-107 decreases early in Alzheimer\u2019s disease and may accelerate disease progression through regulation of \u03b2-site amyloid precursor protein-cleaving enzyme 1","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JAD-2006-9209","article-title":"Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer\u2019s disease","volume":"9","author":"Monte","year":"2006","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/fn.2014.41742","article-title":"Mutations in the exon 7 of Trp53 gene and the level of p53 protein in double transgenic mouse model of Alzheimer\u2019s disease","volume":"52","author":"Dorszewska","year":"2014","journal-title":"Folia Neuropathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4236\/aad.2014.31004","article-title":"Mutations of TP53 gene and oxidative stress in Alzheimer\u2019s disease patients","volume":"3","author":"Dorszewska","year":"2014","journal-title":"Adv. Alzheimer\u2019s Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neulet.2012.11.047","article-title":"P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2","volume":"534","author":"Chen","year":"2013","journal-title":"Neurosci. Lett."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5114\/fn.2019.84828","article-title":"APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer\u2019s disease","volume":"57","author":"Prendecki","year":"2019","journal-title":"Folia Neuropathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/jnc.13507","article-title":"miR-186 is decreased in aged brain and suppresses BACE1 expression","volume":"137","author":"Kim","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.celrep.2013.12.028","article-title":"MiR-342-5p decreases ankyrin G levels in Alzheimer\u2019s disease transgenic mouse models","volume":"6","author":"Sun","year":"2014","journal-title":"Cell Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2011.10.051","article-title":"MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2","volume":"1455","author":"Liang","year":"2012","journal-title":"Brain Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/aps.2016.128","article-title":"LX2343 alleviates cognitive impairments in AD model rats by inhibiting oxidative stress-induced neuronal apoptosis and tauopathy","volume":"38","author":"Guo","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.3390\/ijms14023834","article-title":"Crosstalk between oxidative stress and SIRT1: Impact on the aging process","volume":"14","author":"Salminen","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI28769","article-title":"Oxidative stress mediates tau-induced neurodegeneration in Drosophila","volume":"117","author":"Fulga","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Wang, L., Liu, J., Wang, Q., Jiang, H., Zeng, L., Li, Z., and Liu, R. (2019). MicroRNA-200a-3p mediates neuroprotection in Alzheimer-related deficits and attenuates amyloid-beta overproduction and tau hyperphosphorylation via coregulating BACE1 and PRKACB. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00806"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1002\/jcb.28276","article-title":"miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3\u03b2 in Alzheimer\u2019s disease","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00401-018-1880-5","article-title":"MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways","volume":"136","author":"Li","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1093\/hmg\/ddv377","article-title":"MiR-132\/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo","volume":"24","author":"Smith","year":"2015","journal-title":"Hum. Mol. Gen."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"26697","DOI":"10.1038\/srep26697","article-title":"MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer\u2019s disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"14645","DOI":"10.1523\/JNEUROSCI.1327-13.2013","article-title":"MiR-26b, upregulated in Alzheimer\u2019s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons","volume":"33","author":"Absalon","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2013.12.017","article-title":"Screening of microRNAs associated with Alzheimer\u2019s disease using oxidative stress cell model and different strains of senescence accelerated mice","volume":"338","author":"Zhang","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1002\/jcb.26700","article-title":"Protective effects of microRNA-330 on amyloid \u03b2-protein production, oxidative stress, and mitochondrial dysfunction in Alzheimer\u2019s disease by targeting VAV1 via the MAPK signaling pathway","volume":"119","author":"Zhou","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/molehr\/gax028","article-title":"Dysregulation of the ADAM17\/Notch signalling pathways in endometriosis: From oxidative stress to fibrosis","volume":"23","author":"Santulli","year":"2017","journal-title":"Mol. Hum. Reprod."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000493328","article-title":"Notch signaling promotes development of allergic rhinitis by suppressing Foxp3 expression and treg cell differentiation","volume":"178","author":"Jiao","year":"2019","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_95","first-page":"1541","article-title":"Curcumin attenuates hypoxia\/reoxygenationinduced cardiomyocyte injury by downregulating Notch signaling","volume":"20","author":"Zhu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_96","first-page":"91","article-title":"MicroRNA-98 reduces amyloid \u03b2-protein production and improves oxidative stress and mitochondrial dysfunction through the Notch signaling pathway via HEY2 in Alzheimer\u2019s disease mice","volume":"43","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2018.09.011","article-title":"miR-125b promotes tau phosphorylation by targeting the neural cell adhesion molecule in neuropathological progression","volume":"73","author":"Zhang","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"ref_98","first-page":"2373","article-title":"MicroRNA125b regulates Alzheimer\u2019s disease through SphK1 regulation","volume":"18","author":"Jin","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"9488","DOI":"10.1002\/jcp.26843","article-title":"Effect of microRNA-186 on oxidative stress injury of neuron by targeting interleukin 2 through the janus kinase-signal transducer and activator of transcription pathway in a rat model of Alzheime\u2019s disease","volume":"233","author":"Wu","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00702-015-1405-5","article-title":"Neuropathobiology of non-motor symptoms in Parkinson disease","volume":"122","author":"Jellinger","year":"2015","journal-title":"J. Neural Transm."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fnmol.2018.00236","article-title":"Oxidative stress in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"11","author":"Wei","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1471-4159.2009.06404.x","article-title":"Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons","volume":"111","author":"Hwang","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cellsig.2011.10.017","article-title":"A microRNA, mir133b, suppresses melanopsin expression mediated by failure dopaminergic amacrine cells in RCS rats","volume":"24","author":"Li","year":"2012","journal-title":"Cell Signal."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1523\/JNEUROSCI.0319-07.2007","article-title":"Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration","volume":"27","author":"Caudle","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2014.10.016","article-title":"Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits","volume":"74","author":"Masoud","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12264-016-0061-6","article-title":"MiR-137 and miR-491 negatively regulate dopamine transporter expression and function in neural cells","volume":"32","author":"Jia","year":"2016","journal-title":"Neurosci. Bull."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainresbull.2016.12.004","article-title":"Parkin and PINK1 functions in oxidative stress and neurodegeneration","volume":"133","author":"Barodia","year":"2017","journal-title":"Brain Res. Bull."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbadis.2011.03.007","article-title":"PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons","volume":"1812","author":"Wang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A.Y., Miljan, E.A., Keen, G., Stanyer, L., Hargreaves, I., Klupsch, K., and Deas, E. (2008). PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS ONE, 3.","DOI":"10.1371\/annotation\/17d5aaa1-c6d8-4aad-a9a4-56b2c1220c83"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-016-0121-4","article-title":"miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1)","volume":"11","author":"Kim","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbadis.2014.11.019","article-title":"TNF-alpha regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells","volume":"1852","author":"Prajapati","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbrc.2009.10.025","article-title":"DJ-1 binds to mitochondrial complex I and maintains its activity","volume":"390","author":"Hayashi","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"683920","DOI":"10.1155\/2013\/683920","article-title":"Neuroprotective function of DJ-1 in Parkinson\u2019s disease","volume":"2013","author":"Ariga","year":"2013","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.1074\/jbc.M509079200","article-title":"Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases","volume":"281","author":"Choi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.neurobiolaging.2013.09.027","article-title":"MicroRNA-494 reduces DJ-1 expression and exacerbates neurodegeneration","volume":"35","author":"Xiong","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fnagi.2017.00232","article-title":"MicroRNA-4639 is a regulator of DJ-1 expression and a potential early diagnostic marker for Parkinson\u2019s disease","volume":"9","author":"Chen","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","article-title":"MicroRNA profiling of Parkinson\u2019s disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function","volume":"20","author":"Porta","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","article-title":"Expression of Nrf2 in neurodegenerative diseases","volume":"66","author":"Ramsey","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fnins.2016.00298","article-title":"MicroRNAs: Emerging targets regulating oxidative stress in the models of Parkinson\u2019s disease","volume":"10","author":"Xie","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.freeradbiomed.2015.09.010","article-title":"MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression","volume":"89","author":"Kabaria","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ymthe.2017.08.017","article-title":"Loss of MicroRNA-7 regulation leads to alpha-synuclein accumulation and dopaminergic neuronal loss in vivo","volume":"25","author":"McMillan","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Narasimhan, M., Patel, D., Vedpathak, D., Rathinam, M., Henderson, G., and Mahimainathan, L. (2012). Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051111"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Slota, J.A., and Booth, S.A. (2019). MicroRNAs in neuroinflammation: Implications in disease pathogenesis, biomarker discovery and therapeutic applications. Noncoding RNA, 5.","DOI":"10.3390\/ncrna5020035"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrg1831","article-title":"Genetics of Parkinson disease: Paradigm shifts and future prospects","volume":"7","author":"Farrer","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"alpha-synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","article-title":"Parkinson\u2019s disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death","volume":"26","author":"Martin","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00204-016-1788-6","article-title":"Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells","volume":"91","author":"Perfeito","year":"2017","journal-title":"Arch. Toxicol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/ars.2015.6343","article-title":"Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson\u2019s disease","volume":"24","author":"Deas","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"ref_130","first-page":"342ra378","article-title":"alpha-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease","volume":"8","author":"Barrett","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1073\/pnas.0906277106","article-title":"Repression of alpha-synuclein expression and toxicity by microRNA-7","volume":"106","author":"Junn","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.biopha.2015.08.025","article-title":"MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting alpha-synuclein expression in MPTP-induced Parkinson\u2019s disease mouse","volume":"74","author":"Wang","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","article-title":"Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153","volume":"285","author":"Doxakis","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.febslet.2014.12.014","article-title":"Inhibition of miR-34b and miR-34c enhances alpha-synuclein expression in Parkinson\u2019s disease","volume":"589","author":"Kabaria","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1038\/cddis.2013.73","article-title":"Influence of microRNA deregulation on chaperone-mediated autophagy and alpha-synuclein pathology in Parkinson\u2019s disease","volume":"4","author":"Seow","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"15845","DOI":"10.3390\/ijms150915845","article-title":"Targeted suppression of chaperone-mediated autophagy by miR-320a promotes alpha-synuclein aggregation","volume":"15","author":"Li","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_137","first-page":"938348","article-title":"miR-16-1 promotes the aberrant alpha-synuclein accumulation in parkinson disease via targeting heat shock protein 70","volume":"2014","author":"Zhang","year":"2014","journal-title":"Sci. World J."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fnmol.2016.00128","article-title":"Role of microRNAs in the Regulation of alpha-Synuclein Expression: A Systematic Review","volume":"9","author":"Recasens","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","article-title":"microRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease","volume":"36","author":"Thome","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_142","first-page":"11","article-title":"MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease","volume":"16","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ensci.2018.09.002","article-title":"Differential expression of miRNA 155 and miRNA 146a in Parkinson\u2019s disease patients","volume":"13","author":"Caggiu","year":"2018","journal-title":"eNeurologicalSci"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12974-018-1053-4","article-title":"MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson\u2019s disease","volume":"15","author":"Yao","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.freeradbiomed.2012.05.040","article-title":"Involvement and interplay of Parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders","volume":"53","author":"Wilhelmus","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"Hardiman","year":"2017","journal-title":"Lancet"},{"key":"ref_147","first-page":"252","article-title":"Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis","volume":"30","author":"Volk","year":"2018","journal-title":"Med. Genet."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pneurobio.2016.09.004","article-title":"TDP-43\/FUS in motor neuron disease: Complexity and challenges","volume":"145\u2013146","author":"Guerrero","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-016-1587-4","article-title":"ALS and FTD: An epigenetic perspective","volume":"132","author":"Belzil","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1712323","DOI":"10.1155\/2019\/1712323","article-title":"Aberrations in oxidative stress markers in amyotrophic lateral sclerosis: A systematic review and meta-analysis","volume":"2019","author":"Wang","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fneur.2019.00186","article-title":"An overview of MicroRNAs as biomarkers of ALS","volume":"10","author":"Joilin","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1038\/s41598-018-23139-2","article-title":"Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls","volume":"8","author":"Kovanda","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Ricci, C., Marzocchi, C., and Battistini, S. (2018). MicroRNAs as biomarkers in amyotrophic lateral sclerosis. Cells, 7.","DOI":"10.3390\/cells7110219"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1038\/s41598-018-28366-1","article-title":"MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors","volume":"8","author":"Rizzuti","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fnins.2017.00731","article-title":"Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity","volume":"11","author":"Waller","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Borel, F., Gernoux, G., Sun, H., Stock, R., Blackwood, M., Brown, R.H., and Mueller, C. (2018). Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques. Sci. Transl. Med., 10.","DOI":"10.1126\/scitranslmed.aau6414"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1093\/hmg\/ddt261","article-title":"Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice","volume":"22","author":"Koval","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnmol.2019.00114","article-title":"Decreased glycogenolysis by miR-338-3p promotes regional glycogen accumulation within the spinal cord of amyotrophic lateral sclerosis mice","volume":"12","author":"Li","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1073\/pnas.0801613105","article-title":"miR-34a repression of SIRT1 regulates apoptosis","volume":"105","author":"Yamakuchi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Singh, P., Hanson, P.S., and Morris, C.M. (2017). SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson\u2019s disease. BMC Neurosci., 18.","DOI":"10.1186\/s12868-017-0364-1"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1159\/000491465","article-title":"Nrf2 pathway in age-related neurological disorders: Insights into MicroRNAs","volume":"47","author":"Paladino","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biopha.2015.07.034","article-title":"Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson\u2019s disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway","volume":"75","author":"Ba","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.biopha.2017.03.011","article-title":"Down-regulation of microRNA-142-5p attenuates oxygen-glucose deprivation and reoxygenation-induced neuron injury through up-regulating Nrf2\/ARE signaling pathway","volume":"89","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1007\/s00018-012-1064-8","article-title":"MicroRNA-338 regulates the axonal expression of multiple nuclear-encoded mitochondrial mRNAs encoding subunits of the oxidative phosphorylation machinery","volume":"69","author":"Aschrafi","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2990.2010.01076.x","article-title":"Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3","volume":"36","author":"Shioya","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: A clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.neuron.2015.10.038","article-title":"RAN translation in huntington disease","volume":"88","author":"Ayhan","year":"2015","journal-title":"Neuron"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: From molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fneur.2013.00127","article-title":"Multiple aspects of gene dysregulation in Huntington\u2019s disease","volume":"4","author":"Moumne","year":"2013","journal-title":"Front. Neurol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fnmol.2018.00329","article-title":"A Mitochondria-associated oxidative stress perspective on Huntington\u2019s disease","volume":"11","author":"Zheng","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","article-title":"A microRNA-based gene dysregulation pathway in Huntington\u2019s disease","volume":"29","author":"Johnson","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","article-title":"The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease","volume":"28","author":"Packer","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"10820","DOI":"10.1073\/pnas.0800658105","article-title":"Huntington\u2019s disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies","volume":"105","author":"Savas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.celrep.2018.07.017","article-title":"Huntingtin aggregation impairs autophagy, leading to argonaute-2 accumulation and global MicroRNA dysregulation","volume":"24","author":"Pircs","year":"2018","journal-title":"Cell Rep."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Banez-Coronel, M., Porta, S., Kagerbauer, B., Mateu-Huertas, E., Pantano, L., Ferrer, I., Guzman, M., Estivill, X., and Marti, E. (2012). A pathogenic mechanism in Huntington\u2019s disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genet., 8.","DOI":"10.1371\/journal.pgen.1002481"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","article-title":"Altered microRNA regulation in Huntington\u2019s disease models","volume":"227","author":"Lee","year":"2011","journal-title":"Exp. Neurol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1093\/nar\/gkq575","article-title":"A myriad of miRNA variants in control and Huntington\u2019s disease brain regions detected by massively parallel sequencing","volume":"38","author":"Marti","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","article-title":"The association of CAG repeat length with clinical progression in Huntington disease","volume":"66","author":"Rosenblatt","year":"2006","journal-title":"Neurology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbadis.2011.11.014","article-title":"Antioxidants in Huntington\u2019s disease","volume":"1822","author":"Johri","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00702-009-0364-0","article-title":"Oxidative stress and plasma aminopeptidase activity in Huntington\u2019s disease","volume":"117","author":"Duran","year":"2010","journal-title":"J. Neural. Transm."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00018-017-2591-0","article-title":"Stress-induced changes in miRNA biogenesis and functioning","volume":"75","author":"Olejniczak","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"H2512","DOI":"10.1152\/ajpheart.00233.2008","article-title":"Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis","volume":"295","author":"Asada","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Inukai, S., de Lencastre, A., Turner, M., and Slack, F. (2012). Novel microRNAs differentially expressed during aging in the mouse brain. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0040028"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1093\/nar\/gkw116","article-title":"Distribution of miRNA expression across human tissues","volume":"44","author":"Ludwig","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Agarwal, V., Bell, G.W., Nam, J.W., and Bartel, D.P. (2015). Predicting effective microRNA target sites in mammalian mRNAs. Elife, 4.","DOI":"10.7554\/eLife.05005"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/156652411794859250","article-title":"Practical aspects of microRNA target prediction","volume":"11","author":"Witkos","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fgene.2015.00340","article-title":"Transfection of microRNA mimics should be used with caution","volume":"6","author":"Jin","year":"2015","journal-title":"Front. Genet."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1523\/JNEUROSCI.0600-12.2013","article-title":"Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes","volume":"33","author":"Jovicic","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.molcel.2014.02.013","article-title":"Global analyses of the effect of different cellular contexts on microRNA targeting","volume":"53","author":"Nam","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuron.2011.11.010","article-title":"Cell-type-based analysis of microRNA profiles in the mouse brain","volume":"73","author":"He","year":"2012","journal-title":"Neuron"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.febslet.2015.04.054","article-title":"A toolbox for miRNA analysis","volume":"589","author":"Svoboda","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fncel.2013.00163","article-title":"Plasmid-based target protectors allow specific blockade of miRNA silencing activity in mammalian developmental systems","volume":"7","author":"Knauss","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1126\/science.aad2509","article-title":"Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure","volume":"350","author":"Amin","year":"2015","journal-title":"Science"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"22312","DOI":"10.1038\/srep22312","article-title":"CRISPR\/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo","volume":"6","author":"Chang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1261\/rna.066282.118","article-title":"MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs","volume":"24","author":"Kurata","year":"2018","journal-title":"RNA"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuron.2019.01.035","article-title":"Neuron-specific genome modification in the adult rat brain using CRISPR-Cas9 transgenic rats","volume":"102","author":"Back","year":"2019","journal-title":"Neuron"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molcel.2017.09.029","article-title":"Methods and applications of CRISPR-mediated base editing in eukaryotic genomes","volume":"68","author":"Hess","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nbt.4194","article-title":"Optimized base editors enable efficient editing in cells, organoids and mice","volume":"36","author":"Zafra","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature26155","article-title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity","volume":"556","author":"Hu","year":"2018","journal-title":"Nature"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Anzalone, A.V., Randolph, P.B., Davis, J.R., Sousa, A.A., Koblan, L.W., Levy, J.M., Chen, P.J., Wilson, C., Newby, G.A., and Raguram, A. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature.","DOI":"10.1038\/s41586-019-1711-4"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/hum.2015.065","article-title":"Prospects of neurotrophic factors for Parkinson\u2019s disease: Comparison of protein and gene therapy","volume":"26","author":"Domanskyi","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrneurol.2016.196","article-title":"Precision medicine for disease modification in Parkinson disease","volume":"13","author":"Espay","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cell.2016.09.027","article-title":"Molecular diversity of midbrain development in mouse, human, and stem cells","volume":"167","author":"Gyllborg","year":"2016","journal-title":"Cell"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/mds.27296","article-title":"New developments in genetic rat models of Parkinson\u2019s disease","volume":"33","author":"Creed","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(11)70227-7","article-title":"Modelling of Parkinson\u2019s disease in mice","volume":"10","author":"Chesselet","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnana.2014.00155","article-title":"Parkinson\u2019s disease: Animal models and dopaminergic cell vulnerability","volume":"8","author":"Blesa","year":"2014","journal-title":"Front. Neuroanat."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/ng1914","article-title":"Diversity of microRNAs in human and chimpanzee brain","volume":"38","author":"Berezikov","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"E1106","DOI":"10.1073\/pnas.1420955112","article-title":"Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs","volume":"112","author":"Londin","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/hmg\/ddt655","article-title":"Human-specific microRNA regulation of FOXO1: Implications for microRNA recognition element evolution","volume":"23","author":"McLoughlin","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fgene.2017.00034","article-title":"Unveiling the impact of the genomic architecture on the evolution of vertebrate microRNAs","volume":"8","author":"Franca","year":"2017","journal-title":"Front. Genet."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41467-018-07981-6","article-title":"Single-cell microRNA-mRNA co-sequencing reveals non-genetic heterogeneity and mechanisms of microRNA regulation","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.neuron.2018.10.033","article-title":"Best practices for translational disease modeling using human iPSC-derived neurons","volume":"100","author":"Engle","year":"2018","journal-title":"Neuron"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neurobiolaging.2018.05.032","article-title":"MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients","volume":"69","author":"Tolosa","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1279250","DOI":"10.1155\/2019\/1279250","article-title":"Approaches and methods to measure oxidative stress in clinical samples: Research applications in the cancer field","volume":"2019","author":"Katerji","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Grenier, K., Kao, J., and Diamandis, P. (2019). Three-dimensional modeling of human neurodegeneration: Brain organoids coming of age. Mol. Psychiatry.","DOI":"10.1038\/s41380-019-0500-7"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"16153","DOI":"10.1523\/JNEUROSCI.1510-14.2014","article-title":"A competitive advantage by neonatally engrafted human glial progenitors yields mice whose brains are chimeric for human glia","volume":"34","author":"Windrem","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/cne.24500","article-title":"Target-specific forebrain projections and appropriate synaptic inputs of hESC-derived dopamine neurons grafted to the midbrain of parkinsonian rats","volume":"526","author":"Cardoso","year":"2018","journal-title":"J. Comp. Neurol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","article-title":"Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson\u2019s disease","volume":"15","author":"Grealish","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1016\/j.celrep.2019.08.058","article-title":"HESC-derived dopaminergic transplants integrate into basal ganglia circuitry in a preclinical model of Parkinson\u2019s disease","volume":"28","author":"Adler","year":"2019","journal-title":"Cell Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/23\/6055\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:39:01Z","timestamp":1760189941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/23\/6055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,30]]},"references-count":223,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["ijms20236055"],"URL":"https:\/\/doi.org\/10.3390\/ijms20236055","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,30]]}}}